Laimas Jonaitis

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Bruce E. Sands, Laurent Peyrin‐Biroulet, Edward V. Loftus et al. · New England Journal of Medicine · 2019 · 725 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12

Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study

Johan Burisch, Hillel Vardi, Doron Schwartz et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 162 citations · Full text

Medicine, Health Sciences, Clinical Epidemiology +11

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study

Limas Kupčinskas, Pierre Lafolie, Åke Lignell et al. · Phytomedicine · 2008 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy of Per-oral Methylene Blue Formulation for Screening Colonoscopy

Alessandro Repici, Michael B. Wallace, James E. East et al. · Gastroenterology · 2019 · 84 citations · Full text

Medicine, Clinical Pharmacy, Pharmaceutics +11